Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384980 · ClinicalTrials.gov registry record · Phase 1
Saving Life and Limb: FES for the Elderly With PAD
A Phase 1 study, sponsored by MultiCare Health System Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT02384980: Completed Phase 1 study, sponsored by MultiCare Health System Research Institute.
NCT02384980 is a Phase 1 study that has completed, run by MultiCare Health System Research Institute. The registered enrollment target is 43 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02384980, a Phase 1 study, has completed, sponsored by MultiCare Health System Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study will take the first step to improve public health for millions of Americans with Peripheral Arterial Disease who have extreme difficulty walking due to leg pain. The investigators will assess a proof of concept, home administered, functional electrical stimulation (FES) system to resolve pain, improve walking, and enhance quality of life.
Primary Outcome
We will measure the changes in pain scores from baseline to end of intervention and end of post-intervention
Interventions
- DEVICE FES (Gait MyoElectric Stimulator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
What the finished NCT02384980 record still lists
NCT02384980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 1 intervention - of which FES (Gait MyoElectric Stimulator) is the first listed.
NCT02384980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02384980 about?
NCT02384980 is a clinical study titled "Saving Life and Limb: FES for the Elderly With PAD". This study will take the first step to improve public health for millions of Americans with Peripheral Arterial Disease who have extreme difficulty walking due to leg pain. The investigators will assess a proof of concept, home administered, functional electrical stimulation (FES) system to resolve ...
What is the current status of trial NCT02384980?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2014-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02384980?
The interventions under investigation include: FES (Gait MyoElectric Stimulator) (DEVICE).
Who is sponsoring clinical trial NCT02384980?
This trial is sponsored by MultiCare Health System Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02384980's enrollment target sits among peer trials
43 1100th of 2000 higher than 896 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia